60345-97-3

Usage

Uses

Used in Pharmaceutical Industry:
3-(2-Hydroxyethoxy)benzaldehyde is used as a precursor in the synthesis of various pharmaceuticals. Its functional groups and reactivity make it a valuable component in the development of new drugs and medicinal compounds.
Used in Dye Industry:
In the dye industry, 3-(2-Hydroxyethoxy)benzaldehyde is utilized as a reagent in the production of different types of dyes. Its chemical properties contribute to the color and stability of the dyes, making it an essential component in dye synthesis.
Used in Perfume Industry:
3-(2-Hydroxyethoxy)benzaldehyde is used as a fragrance ingredient in the perfume industry. Its aromatic properties make it a valuable component in creating unique and long-lasting scents for various perfumes and fragrances.
Used in Organic Synthesis:
3-(2-Hydroxyethoxy)benzaldehyde is used as a precursor in organic synthesis, allowing for the creation of various chemical compounds and materials. Its versatility and reactivity make it a valuable component in the synthesis of a wide range of organic compounds.
Used in Antimicrobial Applications:
3-(2-Hydroxyethoxy)benzaldehyde is known for its potential antimicrobial properties, making it a candidate for use in various applications where antimicrobial agents are required, such as in the development of disinfectants, sanitizers, and preservatives.
Used in Antioxidant Applications:
Due to its potential antioxidant properties, 3-(2-Hydroxyethoxy)benzaldehyde can be used in applications where antioxidants are needed to prevent oxidation and degradation of materials or to protect against oxidative stress in biological systems.

InChI:InChI=1/C9H10O3/c10-4-5-12-9-3-1-2-8(6-9)7-11/h1-3,6-7,10H,4-5H2

Upstream product

• 96-49-1 [1,3]-dioxolan-2-one 
• 100-83-4 meta-hydroxybenzaldehyde 
• 141072-57-3 1-bromoethanol 
• 107-07-3 2-chloro-ethanol 
• 13605-19-1 2-hydroxyethyl m-tolyl ether 
• 99613-55-5 2-(3-Hydroxymethyl-phenoxy)-ethanol 
• 540-51-2 2-bromoethanol 
• 828242-83-7 3-[2-(tert-butyl-dimethyl-silanyloxy)-ethoxy]-benzaldehyde 

Downstream Products

• 215456-76-1 3-[2-(methoxymalonyloxy)ethoxy]benzaldehyde 

Relevant academic research and scientific papers

A molybdenum based metallomicellar catalyst for controlled and chemoselective oxidation of activated alcohols in aqueous medium

A surfactant based oxodiperoxo molybdenum complex, which could activate molecular oxygen, has been employed as a catalyst for controlled oxidation of benzylic alcohols to corresponding carbonyls. The oxidation reactions were carried out under aqueous environment, however, in the absence of any extraneous base or co-catalyst. Sensitive/oxidizable functional groups like cyano, sulfide, hydroxyl, aryl-hydroxyl, alkene (internal/terminal), alkyne (internal/terminal), and acetal were tolerated during the transformations. Such selectivity is attributed to the mild nature of the catalyst. The methodology could also be scaled-up for multi-gram synthesis and the protocol is likely to find practical use since it requires an inexpensive recyclable-catalyst and easily available oxidant (under green conditions). A plausible mechanism is proposed with the help of preliminary computational study.

Carbon nitride assisted chemoselective C-H bond photo-oxidation of alkylphenolethoxylates in water medium

The unprecedented ability of g-C3N4 to chemoselectively photo-oxidise the methyl group of 2-(4-methylphenoxy)ethanol instead of the easily oxidised oxyethanol fragment has been demonstrated. When g-C3N4 is treat

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

The present invention provides compounds with imaging moieties for imaging a subject. The present invention also relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, a composition or plurality of imaging agents is enriched in 18 F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

Contrast agent and for the use of a synthetic composition, method and system (by machine translation)

The present invention provides compounds with imaging moieties for imaging a subject. The present invention also relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, a composition or plurality of imaging agents is enriched in 18 F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF

Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.

Photoactivatable fluorescein derivatives caged with a (3-hydroxy-2- naphthalenyl)methyl group

The (3-hydroxy-2-naphthalenyl)methyl (NQMP) group represents an efficient photocage for fluorescein-based dyes. Thus, irradiation of the 6-NQMP ether of 2'-hydroxymethylfluorescein with low-intensity UVA light results in a 4-fold increase in emission inte

TREATMENT OF DISEASES BY EPIGENETIC REGULATION

The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be used for treatment and prevention of diseases or disorders that are susceptible to administration of a BET inhibitor.

ALKOXY COMPOUNDS FOR DISEASE TREATMENT

The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these compounds. The subject compositions are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.

PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS

The present invention is directed to practical high-yielding synthetic processes to prepare compounds of general Formula III, IV, V, VII, VIII, IX, X, XII, XIV, and XV. Such compounds are useful as final products or can be used as intermediates and be fur

Dendritic porphyrin-fullerene conjugates: Efficient light-harvesting and charge-transfer events

A novel dendritic C60-H2P(ZnP)3 (P = porphyrin) conjugate gives rise to the successful mimicry of the primary events in photosynthesis, that is, light harvesting, unidirectional energy transfer, charge transfer, and charge